Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.
A large clinical trial in Europe showed that a single dose of nirsevimab reduced infant hospitalizations for RSV-associated lower respiratory tract infections by over 80% over a six-month period.
In a small sample, dog acquisition during the COVID-19 pandemic was linked to a brief rise in cheerfulness, followed by potential declines in well-being, with effects varying by caregiving role and measure.
A new large-scale study of over 2 million women raises questions about age cutoffs in cervical cancer screening policies after findings reveal that women aged 65 and older face significantly higher rates of cervical cancer-related abnormalities and high-risk HPV infections.
A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.
West Nile virus remains the top mosquito-borne illness in the U.S., with high neuroinvasive disease and mortality rates, especially in transplant recipients, according to a new JAMA review.